Fidelity Nasdaq Composite Index ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.21
資產淨值: 99.09
成立日期: 25/09/2003
 
分析
市值分佈:
98.30%
大市值
1.95%
中市值
0.21%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:06) 總持有投資項目: 1005  
0%
 
100%
     10大 (56.46%)
代號 名稱 佔比% ▼ 持有日期
ACDCProFrac Holding Corp0.00430/10/2026
MBLYMobileye Global0.00430/10/2026
TSHATaysha Gene Therapies0.00430/10/2026
TYRATyra Biosciences0.00430/10/2026
NUTXNutex Health Inc.0.00430/09/2026
SNDSmart Sand0.00430/10/2026
BRVEBraveheart Bio Inc.0.00430/10/2026
VLOSVelos Acquisition I Corp0.00430/09/2026
AGNTAgnt Inc0.00330/10/2026
DMRADamora Therapeutics, Inc.0.00330/10/2026
LIMENeutron Holdings Inc0.00330/10/2026
LMRILumexa Imaging Holdings, Inc.0.00330/10/2026
INBXInhibrx Biosciences Inc.0.00330/10/2026
FTEKFuel Tech0.00330/10/2026
MLTXMoonLake Immunotherapeutics0.00330/09/2026
AFYAAfya Limited0.00330/10/2026
INODInnodata0.00330/10/2026
SABRSabre Corp0.00330/09/2026
CEPFCantor Equity Partners IV Inc.0.00330/09/2026
FORRForrester Research0.00330/10/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25    26    27    28    29    30    31    32    33    34    35    36    37    38    39    40    41    42    43    44    45    46   47    48    49    50    51  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.